|
EXECUTIVE SUMMARY
THE COMPANY
- Condax Medical Products LLC (CMP), founded in 1995, specializes exclusively in patented products designed for safe-sex and to help reduce the effects of erectile dysfunction. ALL PRODUCTS APPEAL EQUALLY TO MEN AND WOMEN
- A total of 12 United States patents protect all company products and six ‘peer-reviewed’ research grants from the National Institutes of Health (NIH) totaling nearly $2 million were used to fund product testing
- The company is managed by experienced professional with more than 225 years of condom and medical device experience.
- Condax Medical Products, LLC is dedicated to leading a new era in safer and
more enjoyable sexual activity. The ongoing research by our team of
professionals, who have been approved by the National Institutes of Health
(NIH), will continue to design and deliver products that will change many
prevailing stereotypes about sexual activity and the use of
contraceptives.
THE CONDAX MEDICAL PRODUCTS MISSION
» All products must work safely and reliably.
» All products must present a novel solution to known, but rarely
discussed problems.
» All products must be easily affordable.
All products must use or augment natural processes – with absolutely no negative side effects
- Condom Applicators: 2 FDA Approved applicators (510k), ULTIMATE™ and ZEUS™, enable instant, correct-way-on, one-handed application of ANY condom in less than one second.
-
High Technology Condoms: 1 New Specialty Condom, LEVITRON™, improves on dysfunction by increasing erection retention by 300%, while simultaneously supporting a man and increasing pleasure for both partners – resulting in more pleasure than with no condom at all. 2 new surface treatments make the outside of condoms more slippery while making the inside of the condoms hold on more securely.
- Erectile Dysfunction Cuff: ERECTEX™: A disposable erectile dysfunction support device that is applied externally and enables men to produce and/or maintain a stronger erection.
- Female Condoms: 2 Female Condom devices, FEMEX™ and PERFECT CHOICE™ enable women to take full control over contraception and protection from sexually transmitted infections including HIV/AIDS
These devices that a woman inserts prior to intercourse - increase sensitivity for both partners and withdraw on the male’s penis when intercourse is complete.
MARKET ANALYSIS
- Current US market for erectile dysfunction products exceeds $1 billion (at approximately $10 per use)
- Current world condom production is approximately 20 billion units. The US market is valued at approximately $260 million.
FINANCIAL CONSIDERATIONS
- Investment in Condax Medical Products is expected to lead to lead to an excellent return within 18 months. Gross sales are projected to exceed $50 million within 3 years.
| SALES
|
1st Year
|
2nd Year
|
3rd Year
|
4th Year
|
5th Year |
| ULTIMATE
|
$642,500
|
3,950,000
|
9,680,000
|
13,630,000
|
20,392,500 |
| ZEUS |
$492,500
|
2,950,000
|
7,280,000
|
10,230,000
|
14,750,000 |
| ERECTEX/LEVITRON |
$12,000,000
|
19,000,000
|
26,000,000
|
36,000,000
|
58,000,000 |
| FEMEX/PERFECT CH. |
$5,000,000
|
10,000,000
|
13,000,000
|
16,000,000
|
22,000,000 |
| TOTAL SALES |
$18,135,000
|
$35,900,000
|
$55,960,000
|
$75,860.000
|
$115,142,500 |
- Manufacturing and assembly sources are already identified in the United States, India and Malaysia
- CMP is an ideal candidate for either its own public offering, or for eventual merger into a consumer products, medical products or female products company
|
